Evidence map›Paper›PMID 25885428›Full record

ArticleBlood cancer journal2015

Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients.

T Tao, X Ma, J Yang, J-Y Zou, S-M Ji, Y-S Tan, W Gong, F Du, J Xu, C-M Ye and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.American journal of clinical dermatology · 2018
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

T TaoDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
X Ma1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
J YangDepartment of Clinical Nutrition, The First Affiliated Hospital of Soochow University, Suzhou, China.
J-Y ZouSuzhou Health College, Suzhou, China.
S-M Ji1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Y-S TanDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
W GongDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
F DuDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
J XuDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
C-M YeDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
X-W Tang1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
D-P Wu1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
S-L Xue1] Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [2] Hematopoietic Transplant Institute, Soochow University, Suzhou, China [3] Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China [4] Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedFemaleGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansInterleukin-2 Receptor alpha SubunitMaleMiddle AgedAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedIL2RA protein, humanInterleukin-2 Receptor alpha Subunit

Identifiers

PMID25885428
PMCPMC4450331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.